Spots Global Cancer Trial Database for invasive lobular breast carcinoma
Every month we try and update this database with for invasive lobular breast carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | NCT01706432 | Central Nervous... Invasive Ductal... Invasive Ductal... Invasive Lobula... Invasive Lobula... Liver Metastase... Lobular Breast ... Lung Metastases Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Recurrent Breas... Stage IV Breast... Tubular Ductal ... Tumors Metastat... | hyperfractionat... laboratory biom... stereotactic ra... | 18 Years - | University of Chicago | |
| Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System | NCT06133647 | Ductal Carcinom... Invasive Lobula... | managing Male B... | 18 Years - 85 Years | Methodist Health System | |
| Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 | NCT00967239 | Breast Cancer | DNA analysis polymorphism an... laboratory biom... pharmacogenomic... | 35 Years - | NSABP Foundation Inc | |
| Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer | NCT00960336 | Breast Cancer | pegylated lipos... | 70 Years - | ARCAGY/ GINECO GROUP | |
| Radiation Therapy in Treating Women With Early Stage Breast Cancer | NCT00909909 | Breast Cancer | External beam b... whole breast ir... | 18 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer | NCT00599989 | Breast Cancer Long-term Effec... Skin Reactions ... | adjuvant therap... conventional su... 3-dimensional c... brachytherapy intracavitary b... proton beam rad... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy | NCT01819233 | Ductal Breast C... Invasive Ductal... Invasive Lobula... Lobular Breast ... Recurrent Breas... Stage IA Breast... Stage IB Breast... | Behavioral diet... Therapeutic con... Radiation thera... Counseling inte... Quality-of-life... | 18 Years - | Thomas Jefferson University | |
| Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer | NCT00096343 | Breast Cancer | carboplatin paclitaxel | 18 Years - 120 Years | University of Alabama at Birmingham | |
| Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery | NCT01082211 | Breast Cancer | 3D-Conformal Ex... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Genetics of Women With Lobular Carcinoma in Situ of the Breast | NCT00536718 | Breast Cancer | gene expression... molecular diagn... polymorphism an... protein express... medical chart r... questionnaire a... | - 60 Years | National Cancer Institute (NCI) | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer | NCT00295893 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... Trastuzumab Carboplatin Paclitaxel | 18 Years - 120 Years | City of Hope Medical Center | |
| Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer | NCT00058058 | Breast Cancer Contralateral B... | MRI | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer | NCT00599989 | Breast Cancer Long-term Effec... Skin Reactions ... | adjuvant therap... conventional su... 3-dimensional c... brachytherapy intracavitary b... proton beam rad... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy | NCT01819233 | Ductal Breast C... Invasive Ductal... Invasive Lobula... Lobular Breast ... Recurrent Breas... Stage IA Breast... Stage IB Breast... | Behavioral diet... Therapeutic con... Radiation thera... Counseling inte... Quality-of-life... | 18 Years - | Thomas Jefferson University | |
| Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes | NCT00433589 | Breast Cancer | anthracycline-b... docetaxel and c... tamoxifen Letrozole | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer | NCT04021069 | Breast Cancer Invasive Ductal... Invasive Lobula... | Radiomic, patho... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer | NCT00096343 | Breast Cancer | carboplatin paclitaxel | 18 Years - 120 Years | University of Alabama at Birmingham | |
| Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery | NCT01953588 | Estrogen Recept... HER2-negative B... Invasive Ductal... Invasive Lobula... Recurrent Breas... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | fulvestrant anastrozole | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer | NCT00058058 | Breast Cancer Contralateral B... | MRI | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Radiation Therapy in Treating Women With Invasive Breast Cancer | NCT00301041 | Breast Cancer | laboratory biom... adjuvant therap... radiation thera... | 18 Years - | University of California, San Francisco | |
| Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer | NCT00960336 | Breast Cancer | pegylated lipos... | 70 Years - | ARCAGY/ GINECO GROUP | |
| Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes | NCT00433589 | Breast Cancer | anthracycline-b... docetaxel and c... tamoxifen Letrozole | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | NCT00182793 | Breast Cancer | trastuzumab carboplatin cyclophosphamid... melphalan thiotepa adjuvant therap... autologous-auto... bone marrow abl... radiation thera... | - 65 Years | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
